Dynasty Gene

About:

Dynasty Gene is a Developer of synthetic biology technology and provider of biotechnology consulting services.

Website: http://www.dynastygene.com

Top Investors: ByteDance, MSA Capital, Volcanics Venture, Chaosheng Capital

Description:

Developer of synthetic biology technology and provider of biotechnology consulting services. The company focuses on technology development, technology consulting, technology transfer, and technical services in the biotechnology field, enabling their clients to make advancement in the field of next-generation DNA sequencing (NGS). The company has its own independent intellectual property rights on their Micropore high-throughput DNA synthesis platform, allowing the company to launch a series of products including: liquid biopsy solutions, NGS library capture kits, etc.

Total Funding Amount:

100M CNY

Headquarters Location:

Qingpu, Shanghai, China

Founded Date:

2018-01-01

Contact Email:

support1(AT)dynastygene.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2021-12-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai